BioNTech SE Statistics

Total Valuation

BioNTech SE has a market cap or net worth of EUR 20.07 billion. The enterprise value is 6.91 billion.

Market Cap	20.07B
Enterprise Value	6.91B

Important Dates

The last earnings date was Monday, May 5, 2025.

Earnings Date	May 5, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.51%
Shares Change (QoQ)	+0.03%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	92.35M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	7.31
PB Ratio	1.06
P/TBV Ratio	1.18
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-9.02
EV / Sales	2.64
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-12.97

Financial Position

The company has a current ratio of 10.18, with a Debt / Equity ratio of 0.02.

Current Ratio	10.18
Quick Ratio	9.86
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	-0.55
Interest Coverage	-80.81

Financial Efficiency

Return on equity (ROE) is -3.94% and return on invested capital (ROIC) is -4.05%.

Return on Equity (ROE)	-3.94%
Return on Assets (ROA)	-3.67%
Return on Invested Capital (ROIC)	-4.05%
Return on Capital Employed (ROCE)	-6.50%
Revenue Per Employee	405,538
Profits Per Employee	-113,113
Employee Count	6,772
Asset Turnover	0.13
Inventory Turnover	1.89

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +1.12% in the last 52 weeks. The beta is 1.08, so BioNTech SE's price volatility has been similar to the market average.

Beta (5Y)	1.08
52-Week Price Change	+1.12%
50-Day Moving Average	92.00
200-Day Moving Average	98.97
Relative Strength Index (RSI)	42.70
Average Volume (20 Days)	2,015

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.94

Income Statement

In the last 12 months, BioNTech SE had revenue of EUR 2.75 billion and -766.00 million in losses. Loss per share was -3.19.

Revenue	2.75B
Gross Profit	2.18B
Operating Income	-1.28B
Pretax Income	-791.30M
Net Income	-766.00M
EBITDA	-1.02B
EBIT	-1.28B
Loss Per Share	-3.19

Full Income Statement

Balance Sheet

The company has 14.11 billion in cash and 293.00 million in debt, giving a net cash position of 13.82 billion.

Cash & Cash Equivalents	14.11B
Total Debt	293.00M
Net Cash	13.82B
Net Cash Per Share	n/a
Equity (Book Value)	18.93B
Book Value Per Share	78.73
Working Capital	14.09B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -255.70 million and capital expenditures -276.90 million, giving a free cash flow of -532.60 million.

Operating Cash Flow	-255.70M
Capital Expenditures	-276.90M
Free Cash Flow	-532.60M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 79.39%, with operating and profit margins of -46.49% and -27.89%.

Gross Margin	79.39%
Operating Margin	-46.49%
Pretax Margin	-28.81%
Profit Margin	-27.89%
EBITDA Margin	-37.14%
EBIT Margin	-46.49%
FCF Margin	n/a

Dividends & Yields

BioNTech SE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.51%
Shareholder Yield	0.51%
Earnings Yield	-3.82%
FCF Yield	-2.65%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BioNTech SE has an Altman Z-Score of 8.04.

Altman Z-Score	8.04
Piotroski F-Score	n/a